Add BrightSurf on Google Email

How oxygen radicals protect against cancer

Researchers at Goethe University Frankfurt discovered that Nox4, an enzyme producing H2O2, prevents cancer by keeping phosphatases out of the cell nucleus, thus allowing DNA damage to be recognized and repaired. In its absence, mutated cells multiply uncontrollably, leading to tumour formation.

SourceGoethe University Frankfurt·JournalProceedings of the National Academy of Sciences·DateApr 23, 2021

Lab study solves textbook problem: How cells know their size

A recent study from Dartmouth College has uncovered the mechanism behind how cells determine their size, a crucial process that regulates cell division in growing organisms. The research found that histone H3 plays a key role in this process, releasing an enzyme called Chk1 to bind with another protein and stop cell multiplication.

SourceDartmouth College·JournalCurrent Biology·DateApr 14, 2021

More than the sum of mutations

A new algorithm can predict which genes cause cancer without DNA sequence changes. Researchers have identified 165 previously unknown cancer genes using machine learning technology, interacting closely with well-known cancer genes.

SourceMax-Planck-Gesellschaft·JournalNature Machine Intelligence·DateApr 12, 2021

How to tame a restless genome

Researchers at Cold Spring Harbor Laboratory found that a protein called Asterix/Gtf1 suppresses small specific regions of mobile genetic elements by binding to tRNA molecules. This discovery could lead to understanding how cells protect themselves against these elements and potentially tame an overly restless genome.

SourceCold Spring Harbor Laboratory·JournalCell Reports·DateApr 8, 2021

New Barrett's esophagus monitoring method could aid in easier and more precise prognoses

A new technique for sampling and testing cells from Barrett's esophagus patients can detect specific chromosomal alterations, including the presence of esophageal adenocarcinoma. The approach combines esophageal brushing with massively parallel sequencing to provide an accurate assessment of disease stages and identify high-risk patients.

SourceCase Western Reserve University·JournalGASTROENTEROLOGY·DateMar 22, 2021

Reversing cancer's gluttony

Researchers discovered pancreatic cancer cells employ macropinocytosis, a novel pathway to procure nutrients when autophagy is inhibited, enabling them to thrive despite starvation. A combination of autophagy and macropinocytosis inhibitors resulted in rapid tumor regression in mouse models.

SourceUniversity of California - San Diego·JournalCancer Cell·DateMar 18, 2021

Stimulating the immune system to fight cancer

Researchers from Max Planck Institute of Molecular Physiology have developed a cell-based assay that identifies highly potent IDO1 inhibitors with different mechanisms of action, which could lead to promising immunotherapies for cancer treatment. The new approach overcomes limitations of existing cell-free assays and holds promise for ...

SourceMax Planck Institute of Molecular Physiology·JournalAngewandte Chemie International Edition·DateMar 17, 2021

New tool to dissect the "undruggable"

Researchers at Harvard University have designed a new highly-selective tool to study proteins that are difficult to target with drugs, known as 'undruggable' proteins. The tool uses a nanobody to add or remove specific sugars from proteins, providing a detailed understanding of their function.

SourceHarvard University·JournalNature Chemical Biology·DateMar 11, 2021

Finding their comfort zone

Researchers discovered artificial microswimmers slow down and accumulate in low-fuel regions where their speed is minimized. This finding suggests a new strategy to improve targeted cancer therapy by delivering chemotherapy drugs to the most problematic cells.

SourceGeorge Mason University·JournalScientific Reports·DateFeb 26, 2021

Metabolic response behind reduced cancer cell growth

A study published in Cell Death & Disease found that inhibiting the EZH2 protein can reduce cancer cell growth in multiple myeloma. The researchers discovered that certain metabolic pathways are altered in cells sensitive to EZH2 inhibition, providing potential markers for treatment response.

SourceUppsala University·JournalCell Death and Disease·DateFeb 12, 2021

T cells depressed

Research on T cells reveals that prolonged exposure to antigens can lead to exhaustion, reducing their ability to contribute to immune responses. A new model study identifies dynamic adjustments in T helper cells' states of exhaustion and suggests potential therapeutic targets.

How lipids distribute proteins within cells

Researchers at the University of Seville have solved a long-standing enigma in basic biology by discovering how lipids distribute proteins within cells. Using a new microscopy technology, they found that membrane lipids select and direct specific proteins to correct exit doors.

SourceUniversity of Seville·JournalScience Advances·DateJan 29, 2021

Cholesterol starvation kills lymphoma cells

Researchers at Northwestern University have developed a novel therapy that uses synthetic nanoparticles to trigger the destruction of lymphoma cells by depriving them of cholesterol. This approach has potential for targeting other cancers with an appetite for cholesterol, such as kidney and ovarian cancer.

SourceNorthwestern University·JournalJournal of Biological Chemistry·DateJan 25, 2021